Literature DB >> 5932694

Carcinoma of the esophagus simulating multiple myeloma. Report of a case.

J V Rivera, F M Reyes, R Menéndez-Corrada.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 5932694     DOI: 10.1007/bf02233607

Source DB:  PubMed          Journal:  Am J Dig Dis        ISSN: 0002-9211


× No keyword cloud information.
  19 in total

Review 1.  PLASMA CELL MYELOMA: GAMMA GLOBULIN SYNTHESIS AND STRUCTURE. A REVIEW OF BIOCHEMICAL AND CLINICAL DATA, WITH THE DESCRIPTION OF A NEWLY-RECOGNIZED AND RELATED SYNDROME, "H-GAMMA-2-CHAIN (FRANKLIN'S) DISEASE.

Authors:  E F OSSERMAN; K TAKATSUKI
Journal:  Medicine (Baltimore)       Date:  1963-11       Impact factor: 1.889

2.  MOLECULAR SIEVE IN THE STUDY OF PLASMA PROTEINS.

Authors:  J V RIVERA; E TORO-GOYCO; M L MATOS
Journal:  Am J Med Sci       Date:  1965-04       Impact factor: 2.378

3.  Plasmacytosis and cryoglobulinemia in cancer.

Authors:  M G BOHROD
Journal:  J Am Med Assoc       Date:  1957-05-04

4.  Malignant lymphoma and lymphatic leukemia associated with myeloma-type serum proteins.

Authors:  H A AZAR; W T HILL; E F OSSERMAN
Journal:  Am J Med       Date:  1957-08       Impact factor: 4.965

5.  Carcinoma coexistent with malignant disorders of plasma cells; an autopsy survey.

Authors:  R A WEITZEL
Journal:  Cancer       Date:  1958 May-Jun       Impact factor: 6.860

6.  The differentiation of myelomatosis from other causes of bone marrow plasmacytosis.

Authors:  W A AHERNE
Journal:  J Clin Pathol       Date:  1958-07       Impact factor: 3.411

7.  Bone marrow plasmocytosis; a review of sixty cases.

Authors:  H KLEIN; M BLOCK
Journal:  Blood       Date:  1953-11       Impact factor: 22.113

8.  Bone marrow findings in a case of carcinomatosis; resemblance to myelomatosis.

Authors:  R M HARDISTY
Journal:  Acta Med Scand       Date:  1952-02-16

9.  "Myeloma" serum electrophoretic patterns in conditions other than myelomatosis.

Authors:  J A OWEN; W R PITNEY; J F O'DEA
Journal:  J Clin Pathol       Date:  1959-07       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.